Sol Atriyal Apendiks Kapama İle Antikoagulan Tedavi Karşılaştırması

Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-3414. doi:10.1093/eurheartj/ehae176

Blackshear, J L, and J A Odell. “Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.” The Annals of thoracic surgery vol. 61,2 (1996): 755-9. doi:10.1016/0003-4975(95)00887-X

Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [published correction appears in Lancet. 2009 Nov 7;374(9701):1596]. Lancet. 2009;374(9689):534-542. doi:10.1016/S0140-6736(09)61343-X

Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial [published correction appears in J Am Coll Cardiol. 2014 Sep 16;64(11):1186]. J Am Coll Cardiol. 2014;64(1):1-12. doi:10.1016/j.jacc.2014.04.029

Osmancik P, Herman D, Neuzil P, et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol. 2020;75(25):3122-3135. doi:10.1016/j.jacc.2020.04.067

Turagam MK, Osmancik P, Neuzil P et al. “Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials.” Journal of the American College of Cardiology vol. 76,23 (2020): 2795-2797. doi:10.1016/j.jacc.2020.08.089

Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial. Circulation. 2021;144(19):1543-1552. doi:10.1161/CIRCULATIONAHA.121.057063

Lakkireddy D, Ellis CR, Thaler D, et al. 5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial. J Am Coll Cardiol. 2025;85(11):1141-1153. doi:10.1016/j.jacc.2024.10.101

Kar S, Doshi SK, Alkhouli M, et al. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Am Heart J. 2023;264:123-132. doi:10.1016/j.ahj.2023.05.022

Landmesser U, Skurk C, Tzikas A, et al. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives. Eur Heart J. 2024;45(32):2914-2932. doi:10.1093/eurheartj/ehae398

Friedman DJ, Freeman JV. Amulet LAAO 5-Year Outcomes: Best in Class or Class Effect?. J Am Coll Cardiol. 2025;85(11):1154-1156. doi:10.1016/j.jacc.2024.11.005